Clinical data | |
---|---|
Trade names | Deramaxx |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATCvet code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Protein binding | High (more than 90%) |
Metabolism | Hepatic biotransformation |
Elimination half-life | 3 hours at 2–3 mg/kg |
Excretion | In feces |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.234.875 |
Chemical and physical data | |
Formula | C17H14F3N3O3S |
Molar mass | 397.37 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Deracoxib (trade name Deramaxx) is a nonsteroidal anti-inflammatory drug (NSAID) of the coxib class, used in dogs to treat pain associated with osteoarthritis, or to prevent pain following orthopedic or dental surgery. It is available as beef-flavored tablets.[1]